Global and China Neurodiagnostics Industry Ecological Development and Analysis Report 2023

Report ID: ARS1403 | Category: Healthcare | Pages: 120 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3100.00 Multi User-$5600.00

Report Description
View Table of Contents

Report Summary

In terms of market side, this report researches the Neurodiagnostics revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.

The global Neurodiagnostics market size in 2022 is XX million US dollars, and it is expected to be 12790.0 million US dollars by 2029, with a compound annual growth rate of 7.30% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Neurodiagnostics market include General Electric (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare GmbH (Germany), Canon Inc. (Japan), and Lifelines Neuro (U.S.). The share of the top 3 players in the Neurodiagnostics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Neurodiagnostics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Neurodegenerative Diseases accounted for XX% of Neurodiagnostics market in 2022. Headache Disorders share of XX%.
Hospitals and Surgical Centers accounted for XX% of the Neurodiagnostics market in 2022. Ambulatory Care Settings accounts for XX%.

Report Includes:
This report presents an overview of global market for Neurodiagnostics. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Neurodiagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Neurodiagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurodiagnostics market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Neurodiagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Neurodiagnostics sales, projected growth trends, technology, application and end-user industry.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
General Electric (U.S.)
Koninklijke Philips N.V. (Netherlands)
Siemens Healthcare GmbH (Germany)
Canon Inc. (Japan)
Lifelines Neuro (U.S.)
Natus Medical Incorporated. (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
FUJIFILM Holdings Corporation (Japan)
Mitsar Co. LTD. (Russia)
Advanced Brain Monitoring, Inc. (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
QIAGEN (Germany)
Nihon Kohden Corporation (Japan)
ANT Neuro (Netherlands)
FONAR Corp. (U.S.)
Fujirebio (Japan)
DRG INSTRUMENTS GMBH (Germany)
Tecan Trading AG (Switzerland)
Agilent Technologies, Inc. (U.S.)

Types list
Neurodegenerative Diseases
Headache Disorders
Stroke
Sleep Disorders
Epilepsy
Neuroimaging Technologies
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Nuclear Medicine Imaging (PET, SPECT)
Near Infrared Spectroscopic Imaging (NIRS)
Electroencephalography (EEG)
Magnetoencephalography (MEG)
Voxel-based Morphometry (VBM)
In Vitro Diagnostics
Neuroinformatics

Application list
Hospitals and Surgical Centers
Ambulatory Care Settings
Diagnostic Laboratories and Imaging Centers
Neurology Centers
Academic and Research Institutes

Table of Content

1 Neurodiagnostics Market Introduction and Overview
1.1 Neurodiagnostics Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Neurodiagnostics Revenue and Market Share by Manufacturer
2.2 Manufacturers Neurodiagnostics Production Sites, Area Served, Product Types
2.3 Neurodiagnostics Market Competitive Situation and Trends
2.3.1 Neurodiagnostics Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Neurodiagnostics Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Neurodiagnostics Market Share by Type 2018 VS 2022
3.2 Global Neurodiagnostics Revenue and Market Share by Type
4 Global Neurodiagnostics Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Neurodiagnostics Market Share by Application 2018 VS 2022
4.2 Global Neurodiagnostics Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Neurodiagnostics Market Size (2018-2023)
5.2 Neurodiagnostics Growth Trends Analysis by Regions
5.2.1 Neurodiagnostics Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Neurodiagnostics Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Neurodiagnostics Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Neurodiagnostics Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Neurodiagnostics Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Neurodiagnostics Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1  General Electric (U.S.)
6.1.1 General Electric (U.S.) Company Profile
6.1.2 Neurodiagnostics Product Overview
6.1.3 General Electric (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.1.4 General Electric (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2  Koninklijke Philips N.V. (Netherlands)
6.2.1 Koninklijke Philips N.V. (Netherlands) Company Profile
6.2.2 Neurodiagnostics Product Overview
6.2.3 Koninklijke Philips N.V. (Netherlands) Neurodiagnostics Market Performance (2018-2023)
6.2.4 Koninklijke Philips N.V. (Netherlands) Business Overview
6.2.5 SWOT Analysis
6.3  Siemens Healthcare GmbH (Germany)
6.3.1 Siemens Healthcare GmbH (Germany) Company Profile
6.3.2 Neurodiagnostics Product Overview
6.3.3 Siemens Healthcare GmbH (Germany) Neurodiagnostics Market Performance (2018-2023)
6.3.4 Siemens Healthcare GmbH (Germany) Business Overview
6.3.5 SWOT Analysis
6.4  Canon Inc. (Japan)
6.4.1 Canon Inc. (Japan) Company Profile
6.4.2 Neurodiagnostics Product Overview
6.4.3 Canon Inc. (Japan) Neurodiagnostics Market Performance (2018-2023)
6.4.4 Canon Inc. (Japan) Business Overview
6.4.5 SWOT Analysis
6.5  Lifelines Neuro (U.S.)
6.5.1 Lifelines Neuro (U.S.) Company Profile
6.5.2 Neurodiagnostics Product Overview
6.5.3 Lifelines Neuro (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.5.4 Lifelines Neuro (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6  Natus Medical Incorporated. (U.S.)
6.6.1 Natus Medical Incorporated. (U.S.) Company Profile
6.6.2 Neurodiagnostics Product Overview
6.6.3 Natus Medical Incorporated. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.6.4 Natus Medical Incorporated. (U.S.) Business Overview
6.6.5 SWOT Analysis
6.7  F. Hoffmann-La Roche Ltd (Switzerland)
6.7.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
6.7.2 Neurodiagnostics Product Overview
6.7.3 F. Hoffmann-La Roche Ltd (Switzerland) Neurodiagnostics Market Performance (2018-2023)
6.7.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
6.7.5 SWOT Analysis
6.8  FUJIFILM Holdings Corporation (Japan)
6.8.1 FUJIFILM Holdings Corporation (Japan) Company Profile
6.8.2 Neurodiagnostics Product Overview
6.8.3 FUJIFILM Holdings Corporation (Japan) Neurodiagnostics Market Performance (2018-2023)
6.8.4 FUJIFILM Holdings Corporation (Japan) Business Overview
6.8.5 SWOT Analysis
6.9  Mitsar Co. LTD. (Russia)
6.9.1 Mitsar Co. LTD. (Russia) Company Profile
6.9.2 Neurodiagnostics Product Overview
6.9.3 Mitsar Co. LTD. (Russia) Neurodiagnostics Market Performance (2018-2023)
6.9.4 Mitsar Co. LTD. (Russia) Business Overview
6.9.5 SWOT Analysis
6.10  Advanced Brain Monitoring, Inc. (U.S.)
6.10.1 Advanced Brain Monitoring, Inc. (U.S.) Company Profile
6.10.2 Neurodiagnostics Product Overview
6.10.3 Advanced Brain Monitoring, Inc. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.10.4 Advanced Brain Monitoring, Inc. (U.S.) Business Overview
6.10.5 SWOT Analysis
6.11  Thermo Fisher Scientific, Inc. (U.S.)
6.11.1 Thermo Fisher Scientific, Inc. (U.S.) Company Profile
6.11.2 Neurodiagnostics Product Overview
6.11.3 Thermo Fisher Scientific, Inc. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.11.4 Thermo Fisher Scientific, Inc. (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12  Bio-Rad Laboratories, Inc. (U.S.)
6.12.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
6.12.2 Neurodiagnostics Product Overview
6.12.3 Bio-Rad Laboratories, Inc. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.12.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
6.12.5 SWOT Analysis
6.13  QIAGEN (Germany)
6.13.1 QIAGEN (Germany) Company Profile
6.13.2 Neurodiagnostics Product Overview
6.13.3 QIAGEN (Germany) Neurodiagnostics Market Performance (2018-2023)
6.13.4 QIAGEN (Germany) Business Overview
6.13.5 SWOT Analysis
6.14  Nihon Kohden Corporation (Japan)
6.14.1 Nihon Kohden Corporation (Japan) Company Profile
6.14.2 Neurodiagnostics Product Overview
6.14.3 Nihon Kohden Corporation (Japan) Neurodiagnostics Market Performance (2018-2023)
6.14.4 Nihon Kohden Corporation (Japan) Business Overview
6.14.5 SWOT Analysis
6.15  ANT Neuro (Netherlands)
6.15.1 ANT Neuro (Netherlands) Company Profile
6.15.2 Neurodiagnostics Product Overview
6.15.3 ANT Neuro (Netherlands) Neurodiagnostics Market Performance (2018-2023)
6.15.4 ANT Neuro (Netherlands) Business Overview
6.15.5 SWOT Analysis
6.16  FONAR Corp. (U.S.)
6.16.1 FONAR Corp. (U.S.) Company Profile
6.16.2 Neurodiagnostics Product Overview
6.16.3 FONAR Corp. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.16.4 FONAR Corp. (U.S.) Business Overview
6.16.5 SWOT Analysis
6.17  Fujirebio (Japan)
6.17.1 Fujirebio (Japan) Company Profile
6.17.2 Neurodiagnostics Product Overview
6.17.3 Fujirebio (Japan) Neurodiagnostics Market Performance (2018-2023)
6.17.4 Fujirebio (Japan) Business Overview
6.17.5 SWOT Analysis
6.18  DRG INSTRUMENTS GMBH (Germany)
6.18.1 DRG INSTRUMENTS GMBH (Germany) Company Profile
6.18.2 Neurodiagnostics Product Overview
6.18.3 DRG INSTRUMENTS GMBH (Germany) Neurodiagnostics Market Performance (2018-2023)
6.18.4 DRG INSTRUMENTS GMBH (Germany) Business Overview
6.18.5 SWOT Analysis
6.19  Tecan Trading AG (Switzerland)
6.19.1 Tecan Trading AG (Switzerland) Company Profile
6.19.2 Neurodiagnostics Product Overview
6.19.3 Tecan Trading AG (Switzerland) Neurodiagnostics Market Performance (2018-2023)
6.19.4 Tecan Trading AG (Switzerland) Business Overview
6.19.5 SWOT Analysis
6.20  Agilent Technologies, Inc. (U.S.)
6.20.1 Agilent Technologies, Inc. (U.S.) Company Profile
6.20.2 Neurodiagnostics Product Overview
6.20.3 Agilent Technologies, Inc. (U.S.) Neurodiagnostics Market Performance (2018-2023)
6.20.4 Agilent Technologies, Inc. (U.S.) Business Overview
6.20.5 SWOT Analysis
7 Neurodiagnostics Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Neurodiagnostics Industrial Chain Analysis
8 Neurodiagnostics Industry Dynamic Analysis
8.1 Neurodiagnostics Market Trends Analysis
8.2 Neurodiagnostics Market Drivers Analysis
8.3 Neurodiagnostics Market Challenges Analysis
8.4 Neurodiagnostics Market Restraints Analysis
9 Global Neurodiagnostics Forecast Market Analysis by Type & Application
9.1 Global Neurodiagnostics Revenue Market Forecast by Type (2023-2029)
9.2 Neurodiagnostics Revenue Market Forecast by Application (2023-2029)
10 Global Neurodiagnostics Forecast Market Analysis by Region
10.1 Neurodiagnostics Revenue Market Forecast by Region (2023-2029)
10.2 North America Neurodiagnostics Forecast Market Analysis
10.3 EMEA Neurodiagnostics Forecast Market Analysis
10.4 China Neurodiagnostics Forecast Market Analysis
10.5 Asia-Pacific Neurodiagnostics Forecast Market Analysis
10.6 Latin America Neurodiagnostics Forecast Market Analysis
11 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global and China Neurodiagnostics Industry Ecological Development and Analysis Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?